Results 21 to 30 of about 9,259 (270)

Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective. [PDF]

J Clin Med, 2023
Alcohol septal ablation is a minimally invasive procedure for the treatment of left ventricular outflow tract (LVOT) obstruction in patients with hypertrophic obstructive cardiomyopathy (HOCM) who remain symptomatic despite optimal medical therapy.
Gragnano F, Pelliccia F, Guarnaccia N, Niccoli G, De Rosa S, Piccolo R, Moscarella E, Fabris E, Montone RA, Cesaro A, Porto I, Indolfi C, Sinagra G, Perrone Filardi P, Andò G, Calabrò P, Working Group of Interventional Cardiology of the Italian Society of Cardiology.   +16 more
europepmc   +3 more sources

Early Onset and Progression of Left Ventricular Remodeling After Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy [PDF]

, 2005
Background - Alcohol septal ablation (ASA) reduces left ventricular outflow tract (LVOT) pressure gradient in patients with hypertrophic obstructive cardiomyopathy (HOCM), which leads to left ventricular remodeling.
Willem G. van Dockum, Aernout M. Beek, Folkert J. ten Cate, Jurriën M. ten Berg, Olga Bondarenko, Marco Götte, Jos W. R. Twisk, Mark B.M. Hofman, Cees A. Visser, Albert C. van Rossum   +9 more
openalex   +3 more sources

Rescue alcohol septal ablation in sepsis with multiorgan failure

Indian Heart Journal, 2012
A 55 year old male patient with a diagnosis of hypertrophic cardiomyopathy was admitted with features of sepsis related to cholangitis. Initial management with intravenous (i.v.) fluids and antibiotics did not cause any change in his general condition ...
Parag W. Barwad, S. Ramakrishnan, Sandeep Seth, Balram Bhargava   +3 more
doaj   +4 more sources

Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long‐Term Follow‐Up Study Based on the Euro‐Alcohol Septal Ablation Registry [PDF]

, 2017
Background The long‐term efficacy and safety of alcohol septal ablation ( ASA ) in patients with highly symptomatic hypertrophic obstructive cardiomyopathy has been demonstrated. The aim
Josef Veselka, Lothar Faber, Max Liebregts, Robert Cooper, Jaroslav Januška, Jan Krejčí, Thomas Bartel, Maciej Dąbrowski, Peter Riis Hansen, Vibeke Marie Almaas, Hubert Seggewiß, Dieter Horstkotte, Radka Adlová, Henning Bundgaard, Jurriën M. ten Berg, Rod Stables, Morten K. Jensen   +16 more
openalex   +3 more sources

National experience of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: A long-term multicenter retrospective study. [PDF]

Indian Heart J
Shloido E, Popov K, Chernyshov S, Kashtanov M.   +3 more
europepmc   +2 more sources

Alcohol Septal Ablation [PDF]

Journal of Biomedical and Clinical Research, 2015
Summary Since 1994, alcohol septal ablation (ASA) has been used as a minimally invasive treatment of patients with hypertrophic obstructive cardiomyopathy, resistant to conservative medical therapy. This catheter-based intervention consists of injecting absolute alcohol in a septal perforator to induce infarction of the hypertrophied ...
Sotir T. Marchev, Desislava P. Petrova, Boyko D. Kuzmanov   +2 more
openaire   +2 more sources

The results of alcoholic septal ablation in the treatment of hypertrophic cardiomyopathy [PDF]

Кардіохірургія та інтервенційна кардіологія, 2020
Hypertrophic obstructive cardiomyopathy іs a relatively common condition and one of the most common causes of sudden cardiac death in young age. One of the options for the surgical treatment of this pathology is septal myoectomy, which has been the gold ...
B.M. Todurov, G.I. Kovtun, A.V. Khokhlov, O.V. Pantazi, A.O. Shpachuk, A.Yu. Melnik, A.O. Maksakov, A.S. Batsiun   +7 more
doaj   +1 more source

Hospital Procedural Volume and Clinical Outcomes Following Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Prior national data showed a substantial in‐hospital mortality in septal myectomy (SM) with an inverse volume–outcomes relationship. This study sought to assess the contemporary outcomes of septal reduction therapy and volume–outcome ...
Ahmed M. Altibi, Fares Ghanem, Yuanzi Zhao, Miriam Elman, Joaquin Cigarroa, Babak Nazer, Howard K. Song, Ahmad Masri   +7 more
doaj   +1 more source

Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy [PDF]

International Journal of Cardiology, 2021
The aim of this study was to evaluate short- and long-term outcomes related to dose of alcohol administered during alcohol septal ablation (ASA) in patients with hypertrophic obstructive cardiomyopathy (HOCM). Current guidelines recommend using 1-3 mL of alcohol administered in the target septal perforator artery, but this recommendation is based more ...
Veselka, Josef, Faber, Lothar, Liebregts, Max, Cooper, Robert, Januska, Jaroslav, Kashtanov, Maksim, Dabrowski, Maciej, Hansen, Peter Riis, Seggewiss, Hubert, Bonaventura, Jiri, Polakova, Eva, Hansvenclova, Eva, Bundgaard, Henning, ten Berg, Jurriën, Stables, Rodney Hilton, Jarkovsky, Jiri, Jensen, Morten Kvistholm   +16 more
openaire   +6 more sources

Utilizing Alcohol Septal Ablation for Mitigating Left Ventricular Outflow Tract Obstruction in Cardiac Amyloidosis: A Case Report. [PDF]

Cureus
Girgis K, Feinberg A, Retcho D, Elias T, George A, Gonzalez Garcia G, Beshai R, Chennu G, Patel R, Cohen M.   +9 more
europepmc   +3 more sources